| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |